Wang et al. discovered that high GBP2 expression in proficient-mismatch-repair or microsatellite stability (pMMR/MSS) colorectal cancer patients may have better efficacy of anti-PD-1 therapy [14]. Here, GBP2 is linked to colorectal cancer.